Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo

Figure 1

CCL3 and CCL20 injection recruites F4/80-B220-CD11c+ cells into the peripheral blood in mice. B6 mice were injected via the tail vein with 1 mg of CCL3 and CCL20 or with PBS (control). Peripheral blood was obtained by cardiac puncture at the different time intervals (0 h, 8 h, 16 h, 24 h, 48 h, 72 h, 120 h). F4/80-B220-CD11c+ cells were sorted from PBMNCs and analyzed by FACS. Results are given as means ± SD with 10 mice per group from three independent experiments.

Back to article page